PHIBRO ANIMAL HEALTH CORP

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

· · · · · ·
· · September 30, · · June 30,
As of · · 2026 · · 2026
· · (unaudited)
· (in thousands, except share and per share amounts)
ASSETS · · · · · ·
Cash and cash equivalents	$75,548	$61,419
Short-term investments	7,575	20,575
Accounts receivable, net	221,710	238,794
Inventories, net	567,139	534,883
Other current assets	73,200	79,835
Total current assets	945,172	935,506
Property, plant and equipment, net	372,728	369,174
Intangibles, net	28,305	30,052
Goodwill	60,029	60,045
Other assets	108,488	106,464
Total assets	$1,514,722	$1,501,241
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt	$25,025	$25,025
Accounts payable	136,448	127,314
Accrued expenses and other current liabilities	134,314	164,129
Total current liabilities	295,787	316,468
Revolving credit facility	124,000	116,000
Long-term debt	585,852	591,769
Other liabilities	91,415	91,527
Total liabilities	1,097,054	1,115,764
Commitments and contingencies (Note 9)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 21,105,569 and 21,068,682 shares issued and outstanding at September 30, 2026 and June 30, 2026, respectively; 30,000,000 Class B shares authorized, 19,496,034 shares issued and outstanding at September 30, 2026 and June 30, 2026	4	4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding	—	—
Paid-in capital	139,396	138,592
Retained earnings	377,606	352,958
Accumulated other comprehensive loss	(99,338)	(106,077)
Total stockholders’ equity	417,668	385,477
Total liabilities and stockholders’ equity	$1,514,722	$1,501,241

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.